Literature DB >> 2114388

Oligoclonal immunoglobulin gene rearrangements in Philadelphia chromosome-positive common acute lymphoblastic leukemia.

T Ikeda1, K Kita, K Kawakami, T Ohno, S Seki, K Nasu, T Ueda, T Honjo, S Shirakawa.   

Abstract

The occurrence of more than two rearranged bands of immunoglobulin heavy chain (IgH) genes in B precursor acute lymphoblastic leukemia (ALL) has recently been documented. To elucidate the nature of such leukemias, we studied 30 patients with common ALL, including 6 patients with Philadelphia chromosome (Ph1)-positive ALL, by immunophenotyping and genotyping. In 10 of the 30, Southern blotting showed oligoclonal patterns of IgH gene arrangements, which were frequently detected in Ph1-positive ALL. In one patient of the 10, three rearranged bands of Ig kappa chain genes were detected. Ph1 abnormality and co-expression of myeloid associated antigens were found in 5 and 5 of the 10, respectively. Detection of multiple fragments of IgH genes would be suggestive of multipotent progenitor origin of these ALL.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2114388      PMCID: PMC5918038          DOI: 10.1111/j.1349-7006.1990.tb02573.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


immunoglobulin acute lymphoblastic leukemia Ig heavy chain Ig κ chain Philadelphia chromosome T cell receptor β chain T cell rearranging gene γ
  21 in total

1.  Detection of specific sequences among DNA fragments separated by gel electrophoresis.

Authors:  E M Southern
Journal:  J Mol Biol       Date:  1975-11-05       Impact factor: 5.469

2.  Ambiguous phenotypes and genotypes in 16 children with acute leukemia as characterized by multiparameter analysis.

Authors:  W D Ludwig; C R Bartram; J Ritter; A Raghavachar; W Hiddemann; G Heil; J Harbott; H Seibt-Jung; J V Teichmann; H Riehm
Journal:  Blood       Date:  1988-06       Impact factor: 22.113

3.  Cloning of human immunoglobulin mu gene and comparison with mouse mu gene.

Authors:  N Takahashi; S Nakai; T Honjo
Journal:  Nucleic Acids Res       Date:  1980-12-20       Impact factor: 16.971

4.  Cross-lineage gene rearrangements in human leukemic B-precursor cells occur frequently with V-DJ rearrangements of IgH genes.

Authors:  T Nosaka; K Kita; H Miwa; K Kawakami; T Ikeda; T Ohno; N Matsuoka; Y Arita; S Doi; M Nishikori
Journal:  Blood       Date:  1989-07       Impact factor: 22.113

5.  Philadelphia-positive acute leukemia: lineage promiscuity and inconsistently rearranged breakpoint cluster region.

Authors:  S J Chen; G Flandrin; M T Daniel; F Valensi; L Baranger; D Grausz; A Bernheim; Z Chen; F Sigaux; R Berger
Journal:  Leukemia       Date:  1988-05       Impact factor: 11.528

6.  Immunoglobulin-gene rearrangements as unique clonal markers in human lymphoid neoplasms.

Authors:  A Arnold; J Cossman; A Bakhshi; E S Jaffe; T A Waldmann; S J Korsmeyer
Journal:  N Engl J Med       Date:  1983-12-29       Impact factor: 91.245

7.  Biologic and prognostic significance of the presence of more than two mu heavy-chain genes in childhood acute lymphoblastic leukemia of B precursor cell origin.

Authors:  G R Kitchingman; J Mirro; S Stass; U Rovigatti; S L Melvin; D L Williams; S C Raimondi; S B Murphy
Journal:  Blood       Date:  1986-03       Impact factor: 22.113

8.  Clinical importance of myeloid antigen expression in adult acute lymphoblastic leukemia.

Authors:  R E Sobol; R Mick; I Royston; F R Davey; R R Ellison; R Newman; J Cuttner; J D Griffin; H Collins; D A Nelson
Journal:  N Engl J Med       Date:  1987-04-30       Impact factor: 91.245

9.  Two tandemly organized human genes encoding the T-cell gamma constant-region sequences show multiple rearrangement in different T-cell types.

Authors:  M P Lefranc; T H Rabbitts
Journal:  Nature       Date:  1985 Aug 1-7       Impact factor: 49.962

10.  Continuing rearrangement but absence of somatic hypermutation in immunoglobulin genes of human B cell precursor leukemia.

Authors:  J Bird; N Galili; M Link; D Stites; J Sklar
Journal:  J Exp Med       Date:  1988-07-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.